GLUC · Glucose Health, Inc. · Metrics
Market Cap
$1.58M
Shares
4.55M
GLUC metrics
39 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$0.35
Market cap
$1.58M
Price action
20 metricsPrice change (1W)
-4.8%
Price change (30D)
+16.2%
Price change (3M)
-29.6%
Price change (6M)
-12.9%
Price change (YTD)
+63.6%
Price change (1Y)
+266.8%
Trailing year
Price change (5Y)
-87.3%
52-week high
$0.56
52-week low
$0.02
Change from 52-week high
-37.2%
Change from 52-week low
+1,352.1%
Annualized volatility
219.6%
Annualized volatility (3M)
—
Beta
-0.6
RSI (14D)
49.0
Price vs SMA 50
-10.9%
Price vs SMA 200
+16.7%
Avg volume (3M)
13,472
Relative volume
0.2
Average dollar volume
$4,698
Company
3 metricsSector
Consumer Defensive
Industry
Packaged Foods
Shares outstanding
4.55M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-5.3%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
$57,626
Operating profit (TTM)
−$32,449
Net income (TTM)
−$93,973
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+35.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-356.6%
Debt / equity
—
Current ratio
0.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.1
Interest coverage
-0.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$16,636
Total assets
$26,353
Total debt
$169,923
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$17,253
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$906
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—